Identification of α-cobratoxin in equine plasma by LC-MS/MS for doping control.

The research paper discusses the development of a method to detect α-cobratoxin, a toxin found in cobra venom which has potent analgesic effects, in horse plasma. This detection method aims to combat its misuse in the horseracing industry for performance enhancement and pain suppression.

Background

• The research was motivated by instances of α-cobratoxin being found in the stables of a thoroughbred trainer in the USA back in 2007. Thereafter, the detection of the substance has remained a challenge worldwide in the horseracing industry.
• To address this problem, the researchers aimed to create a method for detecting α-cobratoxin in horse plasma. The development of this method is a crucial step in ensuring fair play in the horseracing industry and the welfare of the horses involved.

Method Development

• The researchers utilized a 3mL plasma sample which was treated with ammonium sulfate at α-cobratoxin’s isoelectric point — the pH at which the molecule carries no net electrical charge.
• The resultant pellet was dissolved in a phosphate buffer and mixed with methanol for precipitation.
• The supernatant – the liquid lying above a solid residue after centrifugation – was then concentrated for extraction on WCX SPE (Weak Cation Exchange Solid Phase Extraction) cartridges.
• Following this, the eluate (the solution that has passed through a column and taken the solute with it) was concentrated through two consecutive filtration steps before it was digested with trypsin.
• The samples were then analyzed using a specialized liquid chromatography–mass spectrometry (LC–MS) instrument, focusing on the product ions of a specific target peptide.

Validation and Conclusion

• The method was validated according to the Association of Official Racing Chemists (AORC) requirements at a detection level of 5 μg/L (640 pmol/L), indicating its ability to reliably detect the presence of α-cobratoxin in equine plasma.
• The method’s lower limit of detection was found to be 1 μg/L (130 pmol/L), demonstrating a level of sensitivity crucial for accurate detections.
• The method was used to successfully detect the presence of α-cobratoxin in a horse’s plasma sample 24 hours post administration of α-cobratoxin, further evidencing the method’s effectiveness.
• The researchers conclude by highlighting the method as the first sensitive, specific, and reliable one for the detection of α-cobratoxin in equine plasma, signaling a significant stride in tackling doping in the horseracing industry.